These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16055200)

  • 21. Are all the hypertensives made equal?
    Flaa A; Kjeldsen SE
    Herz; 2006 Jun; 31(4):323-30. PubMed ID: 16810472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Who inherits what? Genetics of primary hypertension].
    Brand E
    Dtsch Med Wochenschr; 2006 Nov; 131(46):2616-7. PubMed ID: 17096310
    [No Abstract]   [Full Text] [Related]  

  • 23. Genetic profiling and tailored therapy in asthma: are we there yet?
    Lugogo NL; Ginsburg GS; Que LG
    Curr Opin Mol Ther; 2007 Dec; 9(6):528-37. PubMed ID: 18041663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive therapy in the obese hypertensive patient.
    Chrostowska M; Szczech R; Narkiewicz K
    Curr Opin Nephrol Hypertens; 2006 Sep; 15(5):487-92. PubMed ID: 16914960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein therapeutics: new applications for pharmacogenetics.
    Krejsa C; Rogge M; Sadee W
    Nat Rev Drug Discov; 2006 Jun; 5(6):507-21. PubMed ID: 16763661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetics/genomics and personalized medicine.
    Sadée W; Dai Z
    Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R207-14. PubMed ID: 16244319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetics in drug discovery and development: a translational perspective.
    Roses AD
    Nat Rev Drug Discov; 2008 Oct; 7(10):807-17. PubMed ID: 18806753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Genetics and hypertension].
    Ellervik C; Tarnow L; Pedersen EB
    Ugeskr Laeger; 2009 Jun; 171(24):2012-5. PubMed ID: 19523364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetics of antihypertensive drug response.
    Kreutz R
    Curr Hypertens Rep; 2004 Feb; 6(1):15-20. PubMed ID: 14972084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension.
    Iaccarino G; Izzo R; Trimarco V; Cipolletta E; Lanni F; Sorriento D; Iovino GL; Rozza F; De Luca N; Priante O; Di Renzo G; Trimarco B
    Clin Pharmacol Ther; 2006 Dec; 80(6):633-45. PubMed ID: 17178264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methodological quality of pharmacogenetic studies: issues of concern.
    Jorgensen AL; Williamson PR
    Stat Med; 2008 Dec; 27(30):6547-69. PubMed ID: 18837075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive pharmacogenetics: getting the right drug into the right patient.
    Turner ST; Schwartz GL; Chapman AB; Hall WD; Boerwinkle E
    J Hypertens; 2001 Jan; 19(1):1-11. PubMed ID: 11204288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Present day hypertension research is determined by cell biology and genetics. Modern therapies protect the organs].
    Haller H; Schrader J
    MMW Fortschr Med; 2004 Nov; 146(47):39-40. PubMed ID: 15624655
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
    Arranz MJ; de Leon J
    Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in pharmacogenomics of drugs acting on hypertension.
    Trotta R; Donati MB; Iacoviello L
    Pharmacol Res; 2004 Apr; 49(4):351-6. PubMed ID: 15202514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.
    Byun E; Caillier SJ; Montalban X; Villoslada P; Fernández O; Brassat D; Comabella M; Wang J; Barcellos LF; Baranzini SE; Oksenberg JR
    Arch Neurol; 2008 Mar; 65(3):337-44. PubMed ID: 18195134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenomics considerations in the control of hypertension.
    Lupoli S; Salvi E; Barcella M; Barlassina C
    Pharmacogenomics; 2015 Nov; 16(17):1951-64. PubMed ID: 26555875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy.
    Schelleman H; Klungel OH; van Duijn CM; Witteman JC; Hofman A; de Boer A; Stricker BH
    Ann Pharmacother; 2006 Feb; 40(2):212-8. PubMed ID: 16449550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic basis of hypertension for the development of tailored medicine.
    Katsuya T; Morishita R; Rakugi H; Ogihrara T
    Hypertens Res; 2009 Aug; 32(8):643-8. PubMed ID: 19543233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.